This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
E Barkus , S Lewis (2008). Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample. Psychological Medicine. Published online: 21 January 2008. doi:10.1017/S0033291707002619.
E Barkus , J Stirling , R Hopkins , S Lewis (2006). Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 39, 139–178.
DC D'Souza , E Perry , L MacDougall , Y Ammerman , T Cooper , YT Wu , G Braley , R Gueorguieve , JH Krystal (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for research. Neuropsychopharmacology 29, 1558–1572.
M Di Forti , PD Morrison , A Butt , RM Murray (2007). Cannabis use and psychiatric and cognitive disorders: the chicken or the egg? Current Opinion in Psychiatry 20, 228–234.
B Favrat , A Ménétrey , M Augsburger , LE Rothuizen , M Appenseller , T Buclin , M Pin , P Mangin , C Giroud (2005). Two cases of ‘cannabis acute psychosis’ following the administration of oral cannabis. BMC Psychiatry 5, 17–19.
DM Fergusson , LJ Horwood , EM Ridder (2005). Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 100, 354–366.
C Henquet , L Krabbendam , J Spauwen , C Kaplan , R Lieb , HU Wittchen , J van Os (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 330, 11–15.
M Hickman , P Vickerman , J Macleod , J Kirkbride , PB Jones (2007) Cannabis and schizophreia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia. Addiction 102, 597–606.
OJ Mason , CJA Morgan , A Stefanovic , HV Curran (2008). The Psychotomimetic States Inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis. Schizophrenia Research 103, 138–142.
THM Moore , S Zammit , A Lingford-Hughes , TRE Barnes , PB Jones , M Burke , L Lewis (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319–328.
CJA Morgan , HV Curran (2008). Effects of cannabidiol on schizophrenia-like symptoms in cannabis users. British Journal of Psychiatry 192, 306–307.
CJA Morgan , S Rossell , F Pepper , J Smart , J Blackburn , B Brandner , HV Curran (2006). Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Biological Psychiatry 59, 265–272.
A Raine (1991). The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin 17, 555–564.
PD Skosnik , L Spatz-Glenn , S Park (2001). Cannabis use is associated with schizotypy and attentional disinhibition. Schizophrenia Research 48, 83–92.
A Soliman , GA O'Driscoll , J Pruessner , ALV Holahan , I Boileau , D Gagnon , A Dagher (2007). Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study. Neuropsychopharmacology. Published online: 24 October 2007. doi:10.1038/sj.npp.1301597.
UNODC (2007). World Drug Report. United Nations Office on Drugs and Crime, 2007. Vienna, Austria.
JH Williams , NA Wellman , JNP Rawlins (1996). Cannabis use correlates with schizotypy in healthy people. Addiction 91, 869–878.
S Zammit , G Spurlock , H Williams , N Norton , N Williams , MC O'Donovan , MJ Owen (2007). Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. British Journal of Psychiatry 191, 402–407.